Exacta BioScience has secured a $1 million USD financing round to accelerate the development of its bacteriophage-based agricultural biotechnology platform.
The investment supports Exacta’s mission to connect cutting-edge biological research with the agricultural industry — advancing platform development and scale-up capacity.
The round reflects growing confidence in biological research aimed at effective, residue-free approaches for high-value crops.